Role of the fatty acids in ovarian functions: Involvement of Peroxisome Proliferator-Activated Receptors (PPAR) and adipokines;Rôle des acides gras sur les fonctions ovariennes : implications des Peroxisome Proliferator-Activated Receptors (PPAR) et des adipocytokines

Gynecologie Obstetrique et Fertilite

Volumn 36, Issue 12, 2008, Pages 1230-1238

  Dupont, J ^a   Froment, P ^a   Rame C ^a   Pierre, P ^a,b   Coyral Castel, S ^a   Chabrolle, C ^b  

^a UMR85 PHYSIOLOGIE DE LA REPRODUCTION ET DES COMPORTEMENTS   (France)

^b CHU BRETONNEAU   (France)

Author keywords

Adipokines; Embryo; Energy metabolism; Fatty acids; Fatty acids receptors; Female fertility; Granulosa cells; Oocyte

Indexed keywords

ADIPONECTIN; FATTY ACID; LEPTIN; LIVER X RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR;

HUMAN; OOCYTE; OVARY CELL; OVARY FOLLICLE; OVARY FUNCTION; SHORT SURVEY;

EID: 57049099116     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2008.09.012     Document Type: Short Survey

References (99)

1. Lucy M.C., Staples C.R., Michel F.M., Thatcher W.W., and Bolt D.J. Effect of feeding calcium soaps to early postpartum dairy cows on plasma prostaglandin F2a, luteinizing hormone and follicular growth. J Dairy Sci 74 (1991) 483-489
2. Staples C.R., Burke J.M., and Thatcher W.W. Influence of supplemental fats on reproductive tissues and performance of lactating cows. J Dairy Sci 81 (1998) 856-871
3. Ambrose D.J., Kastelic J.P., Corbett R., Pitney P.A., Petit H.V., Small J.A., et al. Lower pregnancy losses in lactating dairy cows fed a diet enriched in alpha-linolenic acid. J Dairy Sci 89 (2006) 3066-3074
4. Bilby T.R., Guzeloglu A., MacLaren L.A., Staples C.R., and Thatcher W.W. Pregnancy, bovine somatotropin, and dietary n-3 fatty acids in lactating dairy cows: II. Endometrial gene expression related to maintance of pregnancy. J Dairy Sci 89 (2006) 3360-3375
5. Robinson R.S., Pushpakumara P.G.A., Cheng Z., Peters A.R., Abayasekara D.R.E., and Wathes D.C. Effects of dietary polyunsaturated fatty acids on ovarian and uterine function in lactating dairy cows. Reproduction 124 (2002) 119-131
6. Mattos R., Staples C.R., and Thatcher W.W. Effects of dietary fatty acids on reproduction in ruminants. Rev Reprod 5 (2000) 38-45
7. Beam S.W., and Butler W.R. Energy balance and ovarian follicle development prior to first ovulation postpartum in dairy cows receiving three levels of dietary fat. Biol Reprod 56 (1997) 133-142
8. Wehrman M.E., Welsh Jr. T.H., and Williams G.L. Diet-induced hyperlipidemia in cattle modifies the intrafollicular cholesterol environment, modulates ovarian follicular dynamics, and hastens the onset of postpartum luteal activity. Biol Reprod 45 (1991) 514-522
9. Hawkins D.E., Niswender K.D., Oss G.M., Moeller C.L., Odde K.G., Sawyer H.R., et al. An increase in serum lipids increases luteal lipid content and alters the disappearance rate of progesterone in cows. J Anim Sci 73 (1995) 541-545
10. Lammoglia M.A., Willard S.T., Oldham J.R., and Randel R.D. Effects of dietary fat and season on steroid hormonal profiles before parturition and on hormonal, cholesterol, triglycerides, follicular patterns, and postpartum reproduction in Brahman cows. J Anim Sci 74 (1996) 2253-2262
11. Grummer R.R., and Carroll D.J. Effects of dietary fat on metabolic disorders and reproductive performance of dairy cattle. J Anim Sci 69 (1991) 3838-3852
12. Knickerbocker J.J., Thatcher W.W., Foster D.B., Wolfenson D., Bartol F.F., and Caton D. Uterine prostaglandin and blood flow responses to estradiol-17 beta in cyclic cattle. Prostaglandins 31 (1986) 757-776
13. Ryan D.P., Spoon R.A., and Williams G.L. Ovarian follicular characteristics, embryo recovery, and embryo viability in heifers fed high-fat diets and treated with follicle-stimulating hormone. J Anim Sci 70 (1992) 3505-3513
14. McEvoy T.G., Coull G.D., Broadbent P.J., Hutchinson J.S., and Speake B.K. Fatty acid composition of lipids in immature cattle, pig and sheep oocytes with intact zona pellucida. J Reprod Fertil 118 (2000) 163-170
15. Kim J.Y., Kinoshita M., Ohnishi M., and Fukui Y. Lipid and fatty acid analysis of fresh and frozen-thawed immature and in vitro matured bovine oocytes. Reproduction 122 (2001) 131-138
16. Zeron Y., Ocheretny A., Kedar O., Borochov A., Sklan D., and Arav A. Seasonal changes in bovine fertility: relation to developmental competence of oocytes, membrane properties and fatty acid composition of follicles. Reproduction 121 (2001) 447-454
17. Zeron Y., Sklan D., and Arav A. Effect of polyunsaturated fatty acid supplementation on biophysical parameters and chilling sensitivity of ewe oocytes. Mol Reprod Dev 61 (2002) 271-278
18. Fouladi-Nashta A.A., Gutierrez C.G., Gong J.G., Garnsworthy P.C., and Webb R. Impact of dietary fatty acids on oocyte quality and development in lactating dairy cows. Biol Reprod 77 (2007) 9-17
19. Thangavelu G., Colazo M.G., Ambrose D.J., Oba M., Okine E.K., and Dyck M.K. Diets enriched in unsaturated fatty acids enhance early embryonic development in lactating Holstein cows. Theriogenology 68 (2007) 949-957
20. Tontonoz P., Hy E., and Spiegelman B.M. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator-activated receptor γ. Curr Opin Genet Dev 5 (1995) 576
21. Kliewer S.A., Sundseth S.S., Jones S.A., Brown P.J., Wisely G.B., Koble C.S., et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94 (1997) 4318-4323
22. Lehmann J.M., Lenhard J.M., Oliver B.B., Ringold G.M., and Kliewer S.A. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272 (1997) 3406-3410
23. Hostetler H.A., Petrescu A.D., Kier A.B., and Schroeder F. Peroxisome proliferator-activated receptor α interacts with high affinity and is conformationally responsive to endogenous ligands. J Biol Chem 280 (2005) 18667-18682
24. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20 (1999) 649-688
25. Forman B.M., Chen J., and Evans R.M. The peroxisome proliferator-activated receptors: ligands and activators. Ann N Y Acad Sci 804 (1996) 266-275
26. Forman B.M., Chan J., and Evans R.M. Hypolipidemic drugs, polyunsaturated fatty acids and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc Natl Acad Sci 94 (1997) 4312-4317
27. Escher P., and Wahli W. Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res 448 (2000) 121-138
28. Gelman L., Michalik L., Desvergne B., and Wahli W. Kinase signaling cascades that modulate peroxisome proliferator-activated receptors. Curr Opin Cell Biol 17 (2005) 216-222
29. Blanquart C., Barbier O., Fruchart J.-C., Staels B., and Glineur C. Peroxisome proliferator-activated receptor α (PPARα) turnover by the ubiquitin-proteasome system controls the ligand - induced expression level of its target genes. J Biol Chem 277 (2002) 37254-37259
30. Shibuya A., Wada K., Nakajima A., Saeki M., Katayama K., Mayumi T., et al. Nitration of PPARγ inhibits ligand-dependent translocation into the nucleus in a macrophage-like cell line, RAW 264. FEBS Lett 525 (2002) 43-47
31. Minge C.E., Robker R.L., and Norman R.J. PPAR Gamma: coordinating Metabolic and Immune Contributions to Female Fertility. PPAR Res 243791 (2008) 1-19
32. Komar C.M., and Curry Jr. T.E. Localization and expression of mRNAs for the peroxisome proliferator-activated receptors in ovarian tissue from naturally cycling and pseudopregnant rats. Biol Reprod 66 (2002) 1531-1539
33. Komar C.M., Braissant O., Wahli W., and Curry Jr. T.E. Expression and localization of PPAR in the rat ovary during follicular development and the periovulatory period. Endocrinology 142 (2001) 4831-4838
34. Cui Y., Miyoshi K., Claudio E., Siebenlist U.K., Gonzalez F.J., Flaws J., et al. Loss of the peroxisome proliferation-activated receptor gamma (PPARγ) does not affect mammary development and propensity for tumor formation but leads to reduced fertility. J Biol Chem 277 (2002) 17830-17835
35. Braissant O., Foufelle F., Scotto C., and Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPAR): tissue distribution of PPAR-α, -β and -γ in the adult rat. Endocrinology 137 (1996) 354-366
36. Schoppee P.D., Garmey J.C., and Veldhuis J.D. Putative activation of the peroxisome proliferator-activated receptor γ impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells. Biol Reprod 66 (2002) 190-198
37. Froment P., Fabre S., Dupont J., Pisslet C., Chesneau D., Staels B., et al. Expression and functional role of peroxisome proliferator-activated receptor γ in ovarian folliculogenesis in the sheep. Biol Reprod 69 (2003) 1665-1674
38. 2: genetic mapping and differential expression of the two isoforms. Biochem Biophys Res Commun 239 (1997) 857-861
39. Löhrke B., Viergutz T., Shahi S.K., Pöhland R., Wollenhaupt K., Goldammer T., et al. Detection and functional characterisation of the transcription factor peroxisome proliferator-activated receptor γ in lutein cells. J Endocrinol 159 (1998) 429-439
40. Lambe K.G., and Tugwood J.D. A human peroxisome-proliferator-activated receptor-γ is activated by inducers of adipogenesis, including thiazolidinedione drugs. Eur J Biochem 239 (1996) 1-7
41. Mu Y.-M., Yanase T., Nishi Y., Waseda N., Oda T., Tanake A., et al. Insulin sensitizer, troglitazone, directly inhibits aromatase activity in human ovarian granulosa cells. Biochem Biophys Res Commun 271 (2000) 710-713
42. Mohan M., Malayer J.R., Geisert R.D., and Morgan G.L. Expression patterns of retinoid X receptors, retinaldehyde dehydrogenase, and peroxisome proliferator-activated receptor gamma in bovine preattachment embryos. Biol Reprod 66 (2002) 700
43. Ibabe A., Bilbano E., and Cajaraville M.P. Expression of peroxisome proliferator-activated receptors in zebrafish (Danio rerio) depending on gender and developmental stage. Histochem Cell Biol 123 (2005) 75-87
44. Dreyer C., and Ellinger-Ziegelbauer H. Retinoic acid receptors and nuclear orphan receptors in the development of Xenopus laevis. Int J Dev Biol 40 (1996) 255-262
45. Komar C.M., and Curry Jr. T.E. Inverse relationship between the expression of messenger ribonucleic acid for peroxisome proliferator-activated receptor γ and P450 side chain cleavage in the rat ovary. Biol Reprod 69 (2003) 549-555
46. Kim J., Sato M., Li Q., Lydon J.P., Demayo F.J., Bagchi I.C., et al. Peroxisome proliferator-activated receptor gamma is a target of progesterone regulation in the preovulatory follicles and controls ovulation in mice. Mol Cell Biol 28 (2008) 1770-1782
47. Minge C.E., Bennett B.D., Norman R.J., and Robker R.L. Peroxisome proliferators activated receptor gamma agonist rosiglitazone reverses the adverse effects of diet-induced obesity on oocyte quality. Endocrinology 149 (2008) 2646-2656
48. Viergutz T., Loehrke B., Poehland R., Becker F., and Kanitz W. Relationship between different stages of the corpus luteum and the expression of the peroxisome proliferator-activated receptor gamma protein in bovine large lutein cells. J Reprod Fertil 118 (2000) 153-161
49. Fan W., Yanase T., Morinaga H., Mu Y.-M., Nomura M., Okabe T., et al. Activation of peroxisome proliferator-activated receptor-γ and retinoid X receptor inhibits aromatase transcription via nuclear factor-κB. Endocrinology 146 (2005) 85-92
50. Keller H., Wahli W., and Perroud M. Signaling cross-talk between peroxisome proliferator-activated receptor/retinoid X receptor and estrogen receptor through estrogen response elements. Mol Endocrinol 9 (1995) 794-804
51. Nuñez S.B., Medin J.A., Braissant O., Kemp L., Wahli W., Ozato K., et al. Retinoid X receptor and peroxisome proliferator-activated receptor activate an estrogen responsive gene independent of the estrogen receptor. Mol Cell Endocrinol 127 (1997) 27-40
52. Qin C., Burghardt R., Smith R., Wormke M., Stewart J., and Safe S. Peroxisome proliferator-activated receptor γ agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor α in MCF-7 breast cancer cells. Cancer Res 63 (2003) 958-964
53. Willis D.S., White J., Brosens S., and Franks S. Effect of 15-deoxy-delta (12,14)-prostaglandin J2 (PGJ2): a peroxisome proliferator activating receptor γ (PPAR-γ) ligand on human ovarian steroidogenesis. Endocrinology (1999) 491
54. McIntuch E.W., and Smith M.F. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in ovarian function. Rev Reprod 3 (1998) 23-30
55. Sang Q.X.A. Complex role of matrix metalloproteinases in angiogenesis. Cell Res 8 (1998) 171-177
56. Liu Y.X. Regulation of the plasminogen activator system in the ovary. Biol Signals Recept 8 (1999) 160-177
57. Delerive P., Furchart J.-C., and Staels B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 169 (2001) 459
58. Espey L.L. Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction. Biol Reprod 50 (1994) 233-238
59. Knobile E., and Neill J.D. The Physiology of Reproduction. Second (1994), Raven Press, New York
60. Meade E., McIntyre T., Zimmerman G., and Prescott S. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J Biol Chem 274 (1999) 8328-8334
61. Reginato M.J., Krakow S.L., Bailey S.T., and Lazar M.A. Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor γ. J Biol Chem 273 (1998) 1855-1858
62. Na H.-K., and Surh Y.-J. Peroxisome proliferator-activated receptor γ (PPARγ) ligands as bifunctional regulators of cell proliferation. Biochem Pharmacol 66 (2003) 1381-1391
63. Elrod H.A., and Sun S.Y. PPARγ and apoptosis in cancer. PPAR Res 704165 (2008) 1-12
64. Mu Y.-M., Yanase T., Nishi Y., Takayanagi R., Goto K., and Nawata H. Combined treatment with specific ligands for PPARγ: RXR nuclear receptor system markedly inhibits the expression of cytochrome P450 arom in human granulosa cancer cells. Mol Cell Endocrinol 181 (2001) 239-248
65. Zhang G.Y., Ahmed N., Riley C., Oliva K., Barker G., Quinn M.A., et al. Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma. Br J Cancer 92 (2005) 113-119
66. Pignatelli M., Cocca C., Santos A., and Perez-Castillo A. Enhancement of BRCA1 gene expression by the peroxisome proliferator-activated receptor γ in the MCF-7 breast cancer cell line. Oncogene 22 (2003) 5446-5450
67. Nicol C.J., Yoon M., Ward J.M., Yamashida M., Fukamachi K., Peters J.M., et al. PPARγ influences susceptibility of DMBA-induced mammary, ovarian and skin carcinogenesis. Carcinogenesis 25 (2004) 1747-1755
68. Steffensen K.R., Robertson K., Gustafsson J.A., and Andersen C.Y. Reduced fertility and inability of oocytes to resume meiosis in mice deficient of the Lxr genes. Mol Cell Endocrinol 256 (2006) 9-16
69. Drouineaud V., Sagot P., Garrido C., Logette E., Deckert V., Gambert P., et al. Inhibition of progesterone production in human luteinized granulosa cells treated with LXR agonists. Mol Hum Reprod 13 (2007) 373-379
70. Auwerx J., and Staels B. Leptin. Lancet 351 (1998) 737-742
71. Bjorbaek C., and Kahn B.B. Leptin signaling in the central nervous system and the periphery. Recent Prog Horm Res 59 (2004) 305-331
72. Chehab F.F., Lim M.E., and Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 12 (1996) 318-320
73. Ahima R.S., Prabakaran D., Mantzoros C., Qu D., Lowell B., Maratos-Flier E., et al. Role of leptin in the neuroendocrine response to fasting. Nature 382 (1996) 250-252
74. Clément K. Génétique de l'obésité humaine. Nutrition Clinique et Métabolisme 16 (2002) 188-192
75. Tartaglia L.A., Dembski M., Weng X.U., Deng N., Culpepper J., Devos R., et al. Identification and expression cloning of a leptin receptor. OB-R. Cell 85 (1995) 1263-1271
76. Nagatani S., Guthikonda P., Thompson R.C., Tsukamura H., Maeda K.I., and Foster D.L. Evidence for GnRH regulation by leptin: leptin administration prevents reduced pulsatile LH secretion during fasting. Neuroendocrinology 67 (1998) 370-376
77. Zachow R.J., and Magoffin D.A. Direct intraovarian effects of leptin: impairment of the synergistic action of insulin-like growth factor-I on follicle-stimulating hormone-dependent estradiol-17 beta production by rat ovarian granulosa cells. Endocrinology 138 (1997) 847-850
78. Loffler S., Aust G., Kohler U., and Spanel-Borowski K. Evidence of leptin expression in normal and polycystic human ovaries. Mol Hum Reprod 12 (2001) 1143-1149
79. Karlsson C., Lindell K., Svenssson E., Bergh C., Lind P., Billig H., et al. Expression of functional leptin receptors in the human ovary. J Clin Endocrinol Metab 82 (1997) 4144-4148
80. Spicer L.J., Chamberlain C.S., and Francisco C.C. Ovarian action of leptin: effects on insulin-like growth factor-I-stimulated function of granulosa and thecal cells. Endocrine 12 (2000) 53-59
81. Karamouti M., Kollia P., Kallitsaris A., Vamvakopoulos N., Kollios G., and Messinis I.E. Growth hormone, insulin-like growth factor I, and leptin interaction in human cultured lutein granulosa cells steroidogenesis. Fertil Steril (2007)
82. Paula-Lopes F.F., Boelhauve M., Habermann F.A., Sinowatz F., and Wolf E. Enhancement of Bovine oocyte maturation by leptin is accompanied by an upregulation in mRNA expression of leptin receptor isoforms in cumulus cells. Mol Reprod Dev 75 (2008) 578-587
83. Paula-Lopes F.F., Boelhauve M., Habermann F.A., Sinowatz F., and Wolf E. Leptin promotes meiotic progression and developmental capacity of bovine oocytes via cumulus cell-independent and dependent mechanisms. Biol Reprod 76 (2007) 532-541
84. Craig J., Zhu H., Dyce P.W., Petrik J., and Li J. Leptin enhances oocyte nuclear and cytoplasmic maturation via the mitogen-activated protein kinase pathway. Endocrinology 145 (2004) 5355-5363
85. Herrid M., Nguyen V.L., Hinch G., and McFarlane J.R. Leptin has concentration and stage-dependent effects on embryonic development in vitro. Reproduction 132 (2006) 247-256
86. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., and Miyagawa J. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
87. Xita N., Georgiou I., Chatzikyriakidou A., Vounatsou M., Papassotiriou G.P., and Papassotiriou I. Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome. Clin Chem 51 (2005) 416-423
88. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., and Pratley R.E. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
89. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 26 (2005) 439-451
90. Bersinger N.A., Birkhauser M.H., and Wunder D.M. Adiponectin as a marker of success in intracytoplasmic sperm injection/embryo transfer cycles. Gynecol Endocrinol 22 (2006) 479-483
91. Gutman G, Barak V, Maslovitz S, Amit A, Lessing JB, Geva E. Recombinant luteinizing hormone induces increased production of ovarian follicular adiponectin in vivo: implications for enhanced insulin sensitivity. Fertil Steril 2008 Apr 26. [Epub ahead of print] in press.
92. Ledoux S., Campos D.B., Lopes F.L., Dobias-Goff M., Palin M.F., and Murphy B.D. Adiponectin induces periovulatory changes in ovarian follicular cells. Endocrinology 147 (2006) 5178-5186
93. Chabrolle C, Tosca L, Rame C, Lecomte P, Royere D, Dupont J. Fertil Steril in press.
94. Chabrolle C., Tosca L., and Dupont J. Regulation of adiponectin and its receptors in rat ovary by human chorionic gonadotrophin treatment and potential involvement of adiponectin in granulosa cell steroidogenesis. Reproduction 133 (2007) 719-731
95. Chabrolle C., Tosca L., Crochet S., Tesseraud S., and Dupont J. Expression of adiponectin and its receptors (AdipoR1 and AdipoR2) in chicken ovary: potential role in ovarian steroidogenesis. Domest Anim Endocrinol 33 (2007) 480-487
96. Chappaz E., Albornoz M.S., Campos D., Che L., Palin M.F., Murphy B.D., et al. Adiponectin enhances in vitro development of swine embryos. Domest Anim Endocrinol 35 (2008) 198-207
97. Liu Y.H., Tsai E.M., Chen Y.L., Chen H.S., Chen Y.C., and Wu L.C. Serum adiponectin levels increase after human chorionic gonadotropin treatment during in vitro fertilization. Gynecol Obstet Invest 62 (2006) 61-65
98. Escobar-Morreale H.F., Villuendas G., Botella-Carretero J.I., Alvarez-Blasco F., Sanchón R., and Luque-Ramírez M. Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. Hum Reprod 21 (2006) 2257-2265
99. Leroy JL, Van Soom A, Opsomer G, Goovaerts IG, Bols PE. Reduced fertility in high-yielding dairy cows: are the oocyte and embryo in danger? Part II. Mechanisms linking nutrition and reduced oocyte and embryo quality in high-yielding dairy cows. Reprod Domest Anim 2008;43:623-32.